Livzon Weisanlian Bismuth Potassium Citrate Tablets / Tinidazole Tablets / Clarithromycin Tablets Combination Package

1. Indications and Usage
Peptic Ulcer: Treatment of duodenal and gastric ulcers with Helicobacter pylori infection, especially recurrent and refractory ulcers.
Chronic Gastritis: Management of chronic gastritis with Helicobacter pylori infection, particularly in patients with severe symptoms unresponsive to standard therapy.
2. Dosage and Administration
Regimen: One pack per day, divided into morning and evening doses.
Bismuth Potassium Citrate (White): 2 tablets, twice daily, 30 minutes before breakfast and dinner.
Tinidazole (Green): 1 tablet, twice daily, after breakfast and dinner.
Clarithromycin (Yellow): 1 tablet, twice daily, after breakfast and dinner.
Duration: The standard course is typically 1 week, or as directed by the physician.
3. Mechanism of Action
Mucosal Protection: Bismuth potassium citrate forms a protective coating on the gastric mucosa and inhibits peptidase activity.
Antimicrobial Action: Tinidazole and clarithromycin exert synergistic antibacterial effects to eradicate Helicobacter pylori.
4. Safety and Warnings
Contraindications: Contraindicated in patients with severe hepatic or renal impairment, electrolyte disturbances, active central nervous system disorders, blood disorders, or those taking terfenadine. Pregnancy and lactation are also contraindications.
Hypersensitivity: Do not use in patients allergic to nitroimidazoles, macrolides, or any component of the combination.
Alcohol Interaction: Alcohol consumption is strictly prohibited during and for at least 3 days after treatment with tinidazole due to the risk of disulfiram-like reactions.
5. Adverse Reactions and Clinical Research
Common Adverse Reactions: Metallic or bitter taste, nausea, abdominal pain, diarrhea, headache, and dizziness.
Stool Discoloration: Bismuth may cause the tongue and stool to turn grayish-black, which is a normal, reversible reaction.
Rare Adverse Reactions: Elevated liver enzymes, skin rashes, urticaria, leukopenia, and allergic reactions.
Clinical Research: Clinical trials have demonstrated that this triple therapy combination achieves high Helicobacter pylori eradication rates.
6. Drug Interactions
Anticoagulants: May potentiate the effects of warfarin; INR and prothrombin time should be monitored.
pH-Dependent Drugs: May decrease the absorption of drugs requiring an acidic environment (e.g., ketoconazole, iron salts).
Antacids: Bismuth potassium citrate should not be taken concurrently with strong antacids.
7. Pharmaceutical Information
Active Ingredients: Bismuth Potassium Citrate, Tinidazole, and Clarithromycin.
Appearance: The package contains white, green, and yellow tablets.
Storage: Store in a tight, light-resistant container at controlled room temperature.